Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1025-1033
Open Access | Times Cited: 693

Showing 1-25 of 693 citing articles:

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 220
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Jennifer Mitchell, Marcela Ot’alora G., Bessel van der Kolk, et al.
Nature Medicine (2023) Vol. 29, Iss. 10, pp. 2473-2480
Open Access | Times Cited: 186
The neural basis of psychedelic action
Alex C. Kwan, David E. Olson, Katrin H. Preller, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1407-1419
Closed Access | Times Cited: 166
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
Roberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 143
Psychedelics reopen the social reward learning critical period
Romain Nardou, Edward J. Sawyer, Young Jun Song, et al.
Nature (2023) Vol. 618, Iss. 7966, pp. 790-798
Open Access | Times Cited: 142
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
A. Becker, Friederike Holze, Tanja Grandinetti, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 4, pp. 886-895
Open Access | Times Cited: 131
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
Joost J. Breeksema, Bouwe Kuin, Jeanine Kamphuis, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 10, pp. 1100-1117
Open Access | Times Cited: 127
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Must Psilocybin Always “Assist Psychotherapy”?
Guy M. Goodwin, Ekaterina Malievskaia, Gregory A. Fonzo, et al.
American Journal of Psychiatry (2023) Vol. 181, Iss. 1, pp. 20-25
Closed Access | Times Cited: 95
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Lisa Burback, Suzette Brémault‐Phillips, Mirjam J. Nijdam, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 4, pp. 557-635
Closed Access | Times Cited: 94
Psychedelic Drug Legislative Reform and Legalization in the US
Joshua S. Siegel, James E. Daily, Demetrius A. Perry, et al.
JAMA Psychiatry (2022) Vol. 80, Iss. 1, pp. 77-77
Open Access | Times Cited: 93
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 82
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
History repeating: guidelines to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 51
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 24
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300501-e0300501
Open Access | Times Cited: 23
Magnesium–ibogaine therapy in veterans with traumatic brain injuries
Kirsten Cherian, Jackob N. Keynan, Lauren Anker, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 373-381
Open Access | Times Cited: 19
Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, Rebecca Weintraub Brendel, Carmel Shachar, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 6, pp. 611-611
Closed Access | Times Cited: 17
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Post‐traumatic stress disorder: evolving conceptualization and evidence, and future research directions
C. R. Brewin, Lukoye Atwoli, Jonathan I. Bisson, et al.
World Psychiatry (2025) Vol. 24, Iss. 1, pp. 52-80
Closed Access | Times Cited: 9
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 79-103
Closed Access | Times Cited: 4
A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials
Stephanie L. Haft, Amanda E. Downey, Marissa Raymond‐Flesch, et al.
Psychiatry Research (2025) Vol. 345, pp. 116359-116359
Open Access | Times Cited: 3
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
Alberto Melani, Marco Bonaso, Letizia Biso, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis
K W Smith, Dakota J. Sicignano, Adrían V. Hernández, et al.
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 4, pp. 463-471
Closed Access | Times Cited: 79
Page 1 - Next Page

Scroll to top